Corbenic Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Corbenic Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$543.48 - $670.97 $2,717 - $3,354	-5 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$574.03 - $680.96 $2,870 - $3,404	5 New	5 $3,000
Q4 2017 Jan 25, 2018	SELL	$358.63 - $469.95 $7,172 - $9,399	-20 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$431.38 - $504.0 $8,627 - $10,080	20	20 $9,000

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Corbenic Partners LLC with notifications on news.